Clinical Trial Update: Variability of Definitions for Survival Endpoints and Surrogate Properties for OS in Sarcoma Trials: a Meta-analysis

View source ↗

Summary

Meta-analysis evaluating how survival endpoints and surrogate properties for overall survival vary across sarcoma trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Snippet

Sponsor: Institut Bergonié | Conditions: Cancer | Status: COMPLETED | Results posted: 2020-12-21